Skerjanec Simona — SEC Form 4 filings
SEC reporting owner CIK 2022163. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-07.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-05-16 to 2026-07-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Avidity Biosciences, Inc. (RNAM) | Director | 3 | — | — | 6 |
| IMMUNIC, INC. (IMUX) | Director | 4 | — | — | 5 |
| Atrium Therapeutics, Inc. (RNA) | Director | 1 | — | — | 1 |
Form 4 filings — Skerjanec Simona
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-07 | 4 | IMMUNIC, INC. (IMUX) | Grant/award (A): 25,370 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | IMMUNIC, INC. (IMUX) | Grant/award (A): 25,370 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Atrium Therapeutics, Inc. (RNA) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Avidity Biosciences, Inc. (RNAM) | Disposition to issuer (D): 6,692 · Disposition to issuer (D): 10,034 (derivative) · Disposition to issuer (D): 42,308 (derivative) | EDGAR |
| 2025-06-12 | 4 | Avidity Biosciences, Inc. (RNA) | Grant/award (A): 6,692 @ $0 · Grant/award (A): 10,034 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | IMMUNIC, INC. (IMUX) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-07-24 | 4 | IMMUNIC, INC. (IMUX) | Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | Avidity Biosciences, Inc. (RNA) | Grant/award (A): 42,308 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2022163 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →